HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chalid Assaf Selected Research

Chalid Assaf Research Topics

Disease

25Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
02/2024 - 01/2006
15Neoplasms (Cancer)
02/2024 - 02/2004
14Mycosis Fungoides
11/2023 - 07/2002
12Lymphoma (Lymphomas)
01/2022 - 07/2002
3Melanoma (Melanoma, Malignant)
04/2022 - 06/2006
3T-Cell Lymphoma (Lymphoma, T Cell)
01/2021 - 04/2007
3Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
01/2021 - 04/2009
2Contact Dermatitis (Eczema, Contact)
01/2022 - 01/2022
2Neoplasm Metastasis (Metastasis)
11/2016 - 04/2015
2Disease Progression
01/2013 - 09/2007
2B-Cell Lymphoma (Lymphoma, B Cell)
06/2010 - 09/2008
2Necrosis
05/2008 - 06/2006
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2024
1Basal Cell Carcinoma (Rodent Ulcer)
03/2024
1Second Primary Neoplasms (Neoplasms, Second)
03/2024
1Sarcoma (Soft Tissue Sarcoma)
03/2024
1Diabetes Mellitus
03/2024
1Skin Neoplasms (Skin Cancer)
03/2024
1Arthritis (Polyarthritis)
02/2024
1Graft vs Host Disease (Graft-Versus-Host Disease)
02/2024
1Exanthema (Rash)
12/2023
1Anemia
12/2023
1Lymphopenia (Lymphocytopenia)
12/2023
1Dermatitis
07/2022
1Infections
01/2022
1Cytokine Release Syndrome
10/2021
1Vasculitis (Vasculitides)
09/2021
1Sezary Syndrome (Sezary Erythroderma)
01/2020
1Pain (Aches)
01/2019
1Acute Promyelocytic Leukemia
01/2016
1Non-Hodgkin Lymphoma (Lymphosarcoma)
04/2013
1Cardiotoxicity
04/2013
1Sepsis (Septicemia)
11/2012
1Bullous Pemphigoid (Pemphigoid)
07/2012
1Pemphigus (Pemphigus Vulgaris)
07/2012
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
06/2010

Drug/Important Bio-Agent (IBA)

4T-Cell Antigen Receptors (T-Cell Receptor)IBA
07/2014 - 07/2002
4LigandsIBA
03/2010 - 06/2006
3Mechlorethamine (Nitrogen Mustard)FDA Link
07/2022 - 01/2022
3Bexarotene (LGD1069)FDA Link
01/2013 - 05/2008
2Bendamustine HydrochlorideFDA Link
01/2023 - 10/2020
2Dimethyl FumarateIBA
01/2023 - 11/2016
2pembrolizumabIBA
04/2022 - 10/2021
21,2-cyclohexanediamine (dach)IBA
01/2022 - 01/2022
2Histone Deacetylase InhibitorsIBA
08/2012 - 06/2009
2Retinoid X Receptors (Retinoid X Receptor)IBA
08/2012 - 05/2008
2Histone Deacetylases (Histone Deacetylase)IBA
08/2012 - 06/2009
2VorinostatFDA Link
08/2012 - 05/2008
2AntigensIBA
07/2012 - 05/2008
2denileukin diftitox (Ontak)FDA Link
04/2010 - 01/2008
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2010 - 03/2009
2Death Domain ReceptorsIBA
03/2010 - 10/2007
2zanolimumabIBA
12/2008 - 04/2007
1Hydrochlorothiazide (Esidrix)FDA LinkGeneric
03/2024
1Janus Kinase InhibitorsIBA
02/2024
1mogamulizumabIBA
12/2023
1Brentuximab VedotinIBA
01/2023
1Ointments (Pastes)IBA
07/2022
1Biomarkers (Surrogate Marker)IBA
04/2022
1GemcitabineFDA Link
01/2022
1Indicators and Reagents (Reagents)IBA
01/2022
1binimetinibIBA
10/2021
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
10/2021
1TransferasesIBA
10/2021
1Creatine Kinase (Creatine Phosphokinase)IBA
10/2021
1encorafenibIBA
10/2021
1Immunoglobulins (Immunoglobulin)IBA
09/2021
1Anaplastic Lymphoma KinaseIBA
01/2021
1indirubinIBA
03/2019
1Reactive Oxygen Species (Oxygen Radicals)IBA
03/2019
1Calcitonin Gene-Related PeptideIBA
01/2019
1GlucocorticoidsIBA
01/2019
1MineralocorticoidsIBA
01/2019
1Protein Isoforms (Isoforms)IBA
11/2016
1Messenger RNA (mRNA)IBA
11/2016
1Arsenic Trioxide (Trisenox)FDA Link
01/2016
1AcidsIBA
01/2016
1RetinoidsIBA
01/2016
1Aurora Kinase AIBA
09/2015
1Doxorubicin (Adriamycin)FDA LinkGeneric
04/2013
1liposomal doxorubicin (Doxil)FDA Link
04/2013
11-dodecylpyridoxal (PLD)IBA
04/2013
1PanobinostatIBA
01/2013
1Anti-Bacterial Agents (Antibiotics)IBA
11/2012
1Retinoic Acid Receptors (Retinoic Acid Receptor)IBA
08/2012
1AutoantibodiesIBA
07/2012
1ParaffinIBA
06/2010
1Interferon-gamma (Interferon, gamma)IBA
06/2010
1Recombinant Fusion ProteinsIBA
04/2010
1Interleukin-2 (IL2)IBA
04/2010

Therapy/Procedure

19Therapeutics
12/2023 - 02/2004
2Drug Therapy (Chemotherapy)
01/2022 - 04/2015
1Stem Cell Transplantation
02/2024
1Photopheresis
12/2023
1Breast Implants (Breast Implant)
01/2021
1Investigational Therapies (Experimental Therapy)
03/2019
1Treatment Delay
11/2016
1Radiotherapy
04/2015
1Combination Drug Therapy (Combination Chemotherapy)
04/2013
1Immunotherapy
06/2010